Company Valuation: S.C. Ropharma S.A.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 117.2 106 95.61 102.3 82.31 92.03
Change - -9.57% -9.83% 6.95% -19.5% 11.8%
Enterprise Value (EV) 1 248.6 232.2 228.5 249.8 224.8 203.1
Change - -6.6% -1.59% 9.35% -10% -9.67%
P/E 17.4x - 10.4x 13.2x -47.7x 45x
PBR 0.59x - 0.41x 0.43x 0.34x 0.36x
PEG - - - -0.8x 0x -0x
Capitalization / Revenue 0.15x 0.12x 0.1x 0.09x 0.06x 0.06x
EV / Revenue 0.31x 0.26x 0.23x 0.22x 0.17x 0.13x
EV / EBITDA 9.92x 7.4x 9.45x 6.9x 5.46x 4.58x
EV / EBIT 23.6x 13.6x 24.7x 12.5x 9.21x 7.84x
EV / FCF -33.7x -65.2x 22.1x 15.8x 26.6x 3.94x
FCF Yield -2.96% -1.53% 4.53% 6.31% 3.76% 25.4%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 0.0132 - 0.018 0.0151 -0.003375 0.004
Distribution rate - - - - - -
Net sales 1 805.9 888.2 1,002 1,120 1,323 1,538
EBITDA 1 25.06 31.36 24.18 36.2 41.19 44.38
EBIT 1 10.55 17.11 9.256 20.02 24.42 25.89
Net income 1 6.753 10.73 9.216 7.718 -1.726 2.181
Net Debt 1 131.3 126.1 132.9 147.6 142.5 111.1
Reference price 2 0.2300 0.2080 0.1870 0.2000 0.1610 0.1800
Nbr of stocks (in thousands) 509,742 509,736 511,267 511,267 511,267 511,267
Announcement Date 28/04/21 28/04/22 27/04/23 25/04/24 05/05/25 28/04/26
1RON in Million2RON
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 25.38M
19.45x0.86x12.87x-.--% 17.42B
23.43x0.41x6.26x1.93% 7.14B
17.88x0.81x8.39x2.1% 6.79B
21.1x0.79x13.68x1.18% 6.29B
17.17x0.76x8.14x2.36% 4.55B
15.73x0.97x6.95x2.86% 4.45B
15.55x0.66x5.55x4.62% 3.46B
17.86x0.38x5.89x1.29% 3.19B
15.67x0.45x7.48x1.35% 3.15B
Average 18.20x 0.68x 8.36x 1.96% 6B
Weighted average by Cap. 18.93x 0.73x 9.60x 1.47%

Y-o-Y evolution of P/E

Valuation ratios - P/E - S.C. Ropharma S.A.

Historical PBR trend

Valuation ratios - PBR - S.C. Ropharma S.A.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - S.C. Ropharma S.A.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - S.C. Ropharma S.A.

  1. Stock Market
  2. Stocks
  3. RPH Stock
  4. Valuation S.C. Ropharma S.A.